![AbbVie Appoints Robert A. Michael as CEO](https://i-invdn-com.investing.com/news/World_News_8_150x108_S_1420026210.jpg)
Please try another search
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Revenue | 289.65 | 323.89 | 390.39 | 274.03 |
Gross Profit | 48.27 | 5.3 | 44.62 | 29.64 |
Operating Income | 10.48 | -46.62 | -5.39 | -12.07 |
Net Income | 5.46 | -71.53 | -23.8 | -2.33 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Assets | 2968.85 | 3009.69 | 3008.46 | |
Total Liabilities | 1161.38 | 1073.12 | 1062.46 | 1016.92 |
Total Equity | 1807.47 | 1947.22 | 1991.55 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -72.92 | 58.51 | -5.74 | 119.86 |
Cash From Investing Activities | -23.79 | 96.28 | -175.1 | |
Cash From Financing Activities | 62.4 | -44.98 | -84.29 | |
Net Change in Cash | -34.19 | 45.88 | -139.45 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review